Jane E. Onken

36 papers receiving 3.2k citations

Jane E. Onken's Hit Papers

Infliximab Maintenance Therapy for Fistulizing Crohn's Disease 2004 · 1.8k citations
1.8k0+7+14Years since publication5001k1.5k

Peers

Jane E. Onken
Comparison fields: 5 of 100
  • Genetics 2.1k
  • Hematology 233
  • Oncology 207
  • Surgery 391
  • Gastroenterology 51
Replace Deborah K. Freese with:
Deborah K. Freese United States
Hanna Sandberg–Gertzén Sweden
Patrick M. Goggin United Kingdom
F Moesgaard Denmark
Piero Luigi Almasio Italy
Ioannis G. Papaconstantinou Greece
Claudio Papi Italy
Pär Myrelid Sweden
Tom Öresland Sweden
Nicola S. Fearnhead United Kingdom
Jane E. Onken relative to Deborah K. Freese United States Deborah K. Freese's profile →
Citations per field
00.5×5×10×14×
Deborah K. Freese · 1×
Citations per year

Countries citing papers authored by Jane E. Onken

Since Specialization
Citations

This map shows the geographic impact of Jane E. Onken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane E. Onken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane E. Onken more than expected).

Fields of papers citing papers by Jane E. Onken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane E. Onken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane E. Onken. The network helps show where Jane E. Onken may publish in the future.

Co-authors

The 25 scholars most cited alongside Jane E. Onken, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jane E. Onken Line = papers co-authored together Jane E. Onken links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
Hit paper breakdown →
20041804
2 2016272
3 2004190
4 2013137
5
Predicting the presence of choledocholithiasis in patients with symptomatic cholelithiasis.
1996108
6 2007102
7 2013100
8 200579
9 199861
10 200856
11 201655
12 200653
13
ERCP and sphincterotomy in the context of laparoscopic cholecystectomy: academic and community practice patterns and results.
199745
14 200243
15 200442
16 200141
17 200235
18 199529
19 201426
20 201525

About Jane E. Onken

Jane E. Onken is a scholar working on Genetics, Gastroenterology, Oncology, Hematology and Public Health, Environmental and Occupational Health, having authored 39 papers that have together received 3.4k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (11 papers), Innovations in Medical Education (6 papers), Colorectal Cancer Screening and Detection (6 papers), Iron Metabolism and Disorders (4 papers), Gastrointestinal Bleeding Diagnosis and Treatment (3 papers), Erythropoietin and Anemia Treatment (2 papers), Gallbladder and Bile Duct Disorders (2 papers) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Genetics (2.1k citations), Hematology (233 citations), Oncology (207 citations), Surgery (391 citations) and Gastroenterology (51 citations). Jane E. Onken has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Bruce E. Sands, Brian G. Feagan, Daniel Rachmilewitz, Bret A. Lashner, Michael A. Kamm, MARION A. BLANK, Douglas C. Wolf, Suzanne Travers, Gary Wild and Frank Anderson. Their work appears in journals such as Gastrointestinal Endoscopy, Clinical Gastroenterology and Hepatology, Gastroenterology, Inflammatory Bowel Diseases and Alimentary Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact